Home > Boards > US Listed > Biotechs > ImmunoGen, Inc. (IMGN)

I view it as a positive that investors

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
skitahoe Member Profile
 
Followed By 78
Posts 3,925
Boards Moderated 0
Alias Born 08/14/03
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 2/14/2020 5:20:14 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2020 4:54:02 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2020 12:40:19 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/14/2020 6:38:07 AM
ImmunoGen Reports Recent Progress and 2019 Financial Results Business Wire - 2/14/2020 6:30:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/13/2020 2:59:40 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/12/2020 3:04:36 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/12/2020 7:53:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/11/2020 9:28:30 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/11/2020 9:28:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/11/2020 9:27:09 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/11/2020 9:26:34 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/11/2020 9:25:29 AM
Schedule 13g Edgar (US Regulatory) - 2/10/2020 9:11:28 AM
ImmunoGen Announces Webcasts of Presentations at Upcoming Conferences Business Wire - 2/6/2020 4:30:00 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/5/2020 11:50:20 AM
ImmunoGen Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire - 2/3/2020 4:30:00 PM
ImmunoGen Announces Conference Call to Discuss Its 2019 Operating Results Business Wire - 1/30/2020 4:01:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/27/2020 4:13:56 PM
ImmunoGen Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares Business Wire - 1/27/2020 4:01:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/23/2020 4:07:59 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/23/2020 4:06:26 PM
ImmunoGen Announces Pricing of Public Offering of Common Stock Business Wire - 1/22/2020 8:44:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/22/2020 4:10:55 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/22/2020 4:08:19 PM
skitahoe   Monday, 06/24/19 06:23:35 PM
Re: None
Post # of 667 
I view it as a positive that investors advised against the executive incentives. A few years ago it was tied to share price improvement, and I'm fine with that, but rewards for being at many years lows makes little sense. I don't believe we'll be down here forever, I'm hoping for new highs, at that time, ask us again.

Gary

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist